Rumors, Untruths In Addition To The GS-7340
.. CL-induced changes in whole-body energy expenditure Longer term CL treatment has been reported to increase whole-body oxygen consumption in mice (Granneman et?al. 2003). In the current study CL treatment increased oxygen consumption (Fig.?(Fig.4A)4A) and energy expenditure (Fig.?(Fig.4C)4C) in WT but not IL-6?/? mice in the light cycle, whereas RER was not different between groups (Fig.?(Fig.4B).4B). In the dark cycle, oxygen consumption (Fig.?(Fig.4D),4D), RER (Fig.?(Fig.4E)4E) GS-7340 solubility dmso and energy expenditure (Fig.?(Fig.4F)4F) were not different between groups. Figure 4 CL 316,243 treatment increases oxygen consumption and heat production in WT but not IL-6?/? mice. WT and whole-body IL-6?/? mice were injected with CL (1.0?mg/kg?bw) or an equivalent volume of sterile saline ... CL-induced increases in COXIV, and Adenylyl cyclase AMPK are attenuated in white adipose tissue from IL-6?/? mice To assess the role of IL-6 in mediating the effects of CL on mitochondrial biogenesis we measured changes in a number of mitochondrial enzymes in adipose tissue from WT and IL-6?/? mice treated with CL for 5?days. As shown in Fig.?Fig.5A,5A, CL treatment increased UCP-1 mRNA expression ?400 fold and 200 fold in eWAT from WT and IL-6?/? mice, respectively (We were unable to consistently detect UCP-1 protein content in eWAT). CL-induced increases in the protein content of CORE1, Cytochrome C, PDH, citrate synthase, and MCAD were similar in eWAT from WT and IL-6?/? mice. Conversely, the induction of COXIV protein content was attenuated in IL-6?/? mice (Fig.?(Fig.5B).5B). Given the reputed role of AMPK as a regulator of mitochondrial biogenesis we assessed changes in the protein content and phosphorylation of AMPK��. CL treatment increased the protein content of AMPK�� in both genotypes, while the phosphorylation of AMPK�� was only increased in WT mice treated with CL (Fig.?(Fig.55B). Figure 5 Treatment with CL 316,243 increases select mitochondrial proteins in white adipose tissue in an IL-6-dependent manner. WT and whole-body IL-6?/? mice were injected with CL (1.0?mg/kg?bw) or an equivalent volume of sterile ... In iWAT UCP-1 mRNA expression BIBF 1120 clinical trial (Fig.?(Fig.5C)5C) was increased to a similar extent in both genotypes following 5?days of CL treatment. The protein content of UCP-1 was increased to a similar extent in iWAT from both WT (1.00?��?0.27 saline, 3.49?��?0.21 CL P?